Epidermal growth factor receptor (EGFR) was identified as a potential crucial receptor gene in Alzheimer’s disease (AD) and Parkinson’s disease (PD) comorbidity via bioinformatics analysis. This evidence concerns the gene EGFR and Alzheimer disease.